AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Bull&Bear | G1 Therapeutics Surges 66% After Acquisition, Nevro Drops 44% on Downgrade
Generated by AI AgentAinvest Movers Radar
Wednesday, Aug 7, 2024 6:00 pm ET1min read
Top Performing Stocks:
G1 Therapeutics (GTHX) surged 66.12%, marking a two-day increase of 78.73%. G1 Therapeutics was acquired by Pharmacosmos.
PetIQ (PETQ) rose by 47.89%. PetIQ agreed to a $1.5 billion privatization deal with the Bancroft Group.
Latham Group (SWIM) increased by 41.48%. Baird maintained an "outperform" rating on Latham Group and raised the price target to $5.50.
Upstart (UPST) climbed 39.51%, posting a three-day gain of 40.15%. The fintech lending company Upstart Holdings saw its stock rise by 38% following its second-quarter earnings report.
Inogen (INGN) rose by 35.95%. Inogen's second-quarter earnings exceeded expectations, leading to a significant pre-market gain in its stock price.
Poor Performing Stocks:
Nevro (NVRO) plummeted by 44.42%. Nevro's stock dropped sharply due to a downgrade in ratings following revised guidance.
Emergent (EBS) declined by 41.99%. Emergent BioSolutions reported a second-quarter loss that exceeded expectations, resulting in a 38.4% drop in stock price.
Office Depot (ODP) fell by 35.25%, continuing a five-day decline of 41.87%. The parent company of Office Depot, ODP, cut its FY24 guidance due to a 10% decrease in sales.
Porch Group (PRCH) decreased by 32.37%. Shares of Porch Group fell after the company reported Q2 financial results that were below expectations and lowered its FY24 guidance.
Additional Financial Details:
High Course Group reported second-quarter operating income of $131.7 million, compared to the Street's estimate of $136.5 million.
G1 Therapeutics (GTHX) surged 66.12%, marking a two-day increase of 78.73%. G1 Therapeutics was acquired by Pharmacosmos.
PetIQ (PETQ) rose by 47.89%. PetIQ agreed to a $1.5 billion privatization deal with the Bancroft Group.
Latham Group (SWIM) increased by 41.48%. Baird maintained an "outperform" rating on Latham Group and raised the price target to $5.50.
Upstart (UPST) climbed 39.51%, posting a three-day gain of 40.15%. The fintech lending company Upstart Holdings saw its stock rise by 38% following its second-quarter earnings report.
Inogen (INGN) rose by 35.95%. Inogen's second-quarter earnings exceeded expectations, leading to a significant pre-market gain in its stock price.
Poor Performing Stocks:
Nevro (NVRO) plummeted by 44.42%. Nevro's stock dropped sharply due to a downgrade in ratings following revised guidance.
Emergent (EBS) declined by 41.99%. Emergent BioSolutions reported a second-quarter loss that exceeded expectations, resulting in a 38.4% drop in stock price.
Office Depot (ODP) fell by 35.25%, continuing a five-day decline of 41.87%. The parent company of Office Depot, ODP, cut its FY24 guidance due to a 10% decrease in sales.
Porch Group (PRCH) decreased by 32.37%. Shares of Porch Group fell after the company reported Q2 financial results that were below expectations and lowered its FY24 guidance.
Additional Financial Details:
High Course Group reported second-quarter operating income of $131.7 million, compared to the Street's estimate of $136.5 million.
Ainvest Movers Radar
Knowing stock market today at a glance
Latest Articles
Galiano Gold Surges 5.1% Despite Lack of Technical Confirmation – What’s Fueling the Move?
Dec.23 2025
NLY Shares Soar 2.51% Intraday on $2.5B Equity Offering Program
Dec.22 2025
Lam Research Soars 13.09% on AI/HPC Demand, Analyst Upgrades
Dec.22 2025
WisdomTree Shares Surge 8.75% as Japan Hedged ETF Outperforms Unhedged 8x in 5 Years
Dec.22 2025
FBS Global Shares Rally 18.39% on Earnings Turnaround, Seven-Day Gains Reach 14.23%
Dec.22 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet